Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/36965

Title:	Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
Authors:	Turkova, Anna Moore, Cecilia L Butler, Karina Compagnucci, Alexandra Saïdi, Yacine Musiime, Victor Nanduudu, Annet Kaudha, Elizabeth Cressey, Tim R Chalermpantmetagul, Suwalai Scott, Karen Harper, Lynda Montero, Samuel Riault, Yoann Bunupuradah, Torsak Volokha, Alla Flynn, Patricia M Bologna, Rosa Ramos Amador, José Tomás Welch, Steven B Nastouli, Eleni Klein, Nigel Giaquinto, Carlo Ford, Deborah Babiker, Abdel Gibb, Diana M View more
Mesh:	Adolescent Benzoxazines Child Drug Administration Schedule Female Follow-Up Studies HIV Infections HIV-1 Humans Male Reverse Transcriptase Inhibitors Treatment Outcome Viral Load Young Adult View more
Issue Date:	2018
Citation:	PLoS ONE.2018;(13)4:e0196239
Abstract:	Weekends off antiretroviral therapy (ART) may help engage HIV-1-infected young people facing lifelong treatment. BREATHER showed short cycle therapy (SCT; 5 days on, 2 days off ART) was non-inferior to continuous therapy (CT) over 48 weeks. Planned follow-up was extended to 144 weeks, maintaining original randomisation.
PMID:	29684092
URI:	https://hdl.handle.net/20.500.12530/36965
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:

File	Description	Size	Format
PMC5912750.pdf		2.62 MB	Adobe PDF	View/Open